Table 2.
Autophagy Regulation | Result | Glioma Model | Ref |
---|---|---|---|
Beclin-1 overexpression | cell proliferation inhibition, cell cycle arrest at the G2/M; apoptosis | U343, U87MG | [89,90] |
STAT3/Bcl-2 downregulation; Beclin-1 overexpression | apoptosis | U87MG | [93] |
miR224-3p overexpression | hypoxia-induced apoptosis; reduced tumor volume | U87MG, U215, athymic nude mice |
[94] |
ULK2 overexpression | autophagic cell death; cell growth and astrocyte transformation inhibition | LN299; NIH nu/nu nude mice |
[95] |
BCL2 Interacting Protein 3 activation | hypoxia-induced cell death | U87MG, U373 | [96] |
Cyclin B1 downregulation/PARP and Caspase-3 upregulation | cell cycle arrest, apoptosis | U251, LN229 | [97] |
AKT/mTOR pathway inhibition | cell growth inhibition; reduced tumor volume | U87MG; A172 nu/nu nude mice |
[99,100,101] |
EMT regulators downregulation/N- and R-cadherin upregulation | inhibits migration and invasion capacity | GL15, U87MG | [102] |
EGFR modulation | inhibits clonogenic and migration | IRT98G, U373MG | [98] |
H3L9 demethylation | suppresses cell proliferation | LN229, U87MG | [103] |
AKT phosphorylation | senescence; reduces tumor growth | U343 athymic nu/nu mice |
[89] |
MAPK14/p38 and PRKAA/AMPK/ULK1 pathway activation | senescence | U87MG | [104] |